The Task Force for Global Health   Report issue

Foundation Phase 3
Founded: Decatur GA United States (1984)

Organization Overview

First Clinical Trial
2017
NCT02929134
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

doxycycline (vibramycin) (3 trials)

Drugs in Other Trials (3)

albendazole (Albenza) (1 trial)

diethylcarbamazine (hetrazan) (1 trial)

ivermectin (stromectol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Elephantiasis (Phase 3)

Elephantiasis, Filarial (Phase 3)

Filariasis (Phase 3)

Lymphedema (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4